Stock GALENA BIOPHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Galena Biopharma Inc Nasdaq

Equities

US3632561086

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Galena Biopharma Inc
05-01 SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level CI
04-29 SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. SLS Stock
  4. Stock
  5. News Galena Biopharma Inc
  6. Official Publications